Imiquimod 1 g | ≥99.5%
LKT Laboratories, Inc.
Imidazoquinoline nucleoside analog; TLR-7/8 agonist, KCNA1/Kv1.1 and KCNA2/Kv1.2 K+ channel partial agonist, TREK-1/K2P2 and TRAAK/K2P4 K+ channel blocker.
More Information Supplier PageSearch Results
Imiquimod 500 mg | ≥99.5%
LKT Laboratories, Inc.
Imidazoquinoline nucleoside analog; TLR-7/8 agonist, KCNA1/Kv1.1 and KCNA2/Kv1.2 K+ channel partial agonist, TREK-1/K2P2 and TRAAK/K2P4 K+ channel blocker.
More Information Supplier PageImiquimod 100 mg | ≥99.5%
LKT Laboratories, Inc.
Imidazoquinoline nucleoside analog; TLR-7/8 agonist, KCNA1/Kv1.1 and KCNA2/Kv1.2 K+ channel partial agonist, TREK-1/K2P2 and TRAAK/K2P4 K+ channel blocker.
More Information Supplier PagePF-03758309 Dihydrochloride 25 mg | ≥99%
LKT Laboratories, Inc.
PF-03758309 Dihydrochloride 5 mg | ≥99%
LKT Laboratories, Inc.
Capsanthin 50 g | Purity Not Available
LKT Laboratories, Inc.
Capsanthin 100 g | Purity Not Available
LKT Laboratories, Inc.
Total Cytotoxicity Test Assay Kit 250 Tests | Purity Not Available
LKT Laboratories, Inc.
Total Cytotoxicity Test Assay Kit 125 Tests | Purity Not Available
LKT Laboratories, Inc.
Colistin Sulphate 5 g | Purity Not Available
LKT Laboratories, Inc.
Polymixin, antimicrobial peptide, induces formation of pores in membrane; NADH quinone reductase inhibitor. Biological Potency: 19366 u/mg
More Information Supplier Page